世界のIgA腎症治療薬市場予測2023-2029：第I相、第II相、第III相

【英語タイトル】IgA Nephropathy Drugs Market, Global Outlook and Forecast 2023-2029

・商品コード：MMG23LY8799
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：60
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のIgA腎症治療薬市場規模と予測を収録しています。・世界のIgA腎症治療薬市場：売上、2018年-2023年、2024年-2029年
・世界のIgA腎症治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のIgA腎症治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「第I相」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

IgA腎症治療薬のグローバル主要企業は、Calliditas Therapeutics、 Travere Therapeutics、 Omeros Corporation、 Novartis International、 Chinook Therapeutics、 Vera Therapeutics、 Otsuka Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、IgA腎症治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のIgA腎症治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のIgA腎症治療薬市場：タイプ別市場シェア、2022年
・第I相、第II相、第III相

世界のIgA腎症治療薬市場：用途別、2018年-2023年、2024年-2029年
世界のIgA腎症治療薬市場：用途別市場シェア、2022年
・臨床治療、薬物実験

世界のIgA腎症治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のIgA腎症治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるIgA腎症治療薬のグローバル売上、2018年-2023年
・主要企業におけるIgA腎症治療薬のグローバル売上シェア、2022年
・主要企業におけるIgA腎症治療薬のグローバル販売量、2018年-2023年
・主要企業におけるIgA腎症治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Calliditas Therapeutics、 Travere Therapeutics、 Omeros Corporation、 Novartis International、 Chinook Therapeutics、 Vera Therapeutics、 Otsuka Pharmaceutical

*************************************************************

・調査・分析レポートの概要
IgA腎症治療薬市場の定義
市場セグメント
世界のIgA腎症治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のIgA腎症治療薬市場規模
世界のIgA腎症治療薬市場規模：2022年 VS 2029年
世界のIgA腎症治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのIgA腎症治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のIgA腎症治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：第I相、第II相、第III相
IgA腎症治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：臨床治療、薬物実験
IgA腎症治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別IgA腎症治療薬市場規模 2022年と2029年
地域別IgA腎症治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Calliditas Therapeutics、 Travere Therapeutics、 Omeros Corporation、 Novartis International、 Chinook Therapeutics、 Vera Therapeutics、 Otsuka Pharmaceutical
...

IgA nephropathy, also known as Berger’s disease, is a kidney disease that occurs when IgA deposits build up in the kidneys, causing inflammation that damages kidney tissues. IgA is an antibody—a protein made by the immune system to protect the body from foreign substances such as bacteria or viruses.
This report aims to provide a comprehensive presentation of the global market for IgA Nephropathy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IgA Nephropathy Drugs. This report contains market size and forecasts of IgA Nephropathy Drugs in global, including the following market information:
Global IgA Nephropathy Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global IgA Nephropathy Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Phase I Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of IgA Nephropathy Drugs include Calliditas Therapeutics, Travere Therapeutics, Omeros Corporation, Novartis International, Chinook Therapeutics, Vera Therapeutics and Otsuka Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the IgA Nephropathy Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global IgA Nephropathy Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global IgA Nephropathy Drugs Market Segment Percentages, by Type, 2022 (%)
Phase I
Phase II
Phase III
Global IgA Nephropathy Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global IgA Nephropathy Drugs Market Segment Percentages, by Application, 2022 (%)
Clinical Treatment
Drug Experiment
Global IgA Nephropathy Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global IgA Nephropathy Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies IgA Nephropathy Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies IgA Nephropathy Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Calliditas Therapeutics
Travere Therapeutics
Omeros Corporation
Novartis International
Chinook Therapeutics
Vera Therapeutics
Otsuka Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of IgA Nephropathy Drugs, market overview.
Chapter 2: Global IgA Nephropathy Drugs market size in revenue.
Chapter 3: Detailed analysis of IgA Nephropathy Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of IgA Nephropathy Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 IgA Nephropathy Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global IgA Nephropathy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global IgA Nephropathy Drugs Overall Market Size
2.1 Global IgA Nephropathy Drugs Market Size: 2022 VS 2029
2.2 Global IgA Nephropathy Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top IgA Nephropathy Drugs Players in Global Market
3.2 Top Global IgA Nephropathy Drugs Companies Ranked by Revenue
3.3 Global IgA Nephropathy Drugs Revenue by Companies
3.4 Top 3 and Top 5 IgA Nephropathy Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies IgA Nephropathy Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 IgA Nephropathy Drugs Players in Global Market
3.6.1 List of Global Tier 1 IgA Nephropathy Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 IgA Nephropathy Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global IgA Nephropathy Drugs Market Size Markets, 2022 & 2029
4.1.2 Phase I
4.1.3 Phase II
4.1.4 Phase III
4.2 By Type – Global IgA Nephropathy Drugs Revenue & Forecasts
4.2.1 By Type – Global IgA Nephropathy Drugs Revenue, 2018-2023
4.2.2 By Type – Global IgA Nephropathy Drugs Revenue, 2024-2029
4.2.3 By Type – Global IgA Nephropathy Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global IgA Nephropathy Drugs Market Size, 2022 & 2029
5.1.2 Clinical Treatment
5.1.3 Drug Experiment
5.2 By Application – Global IgA Nephropathy Drugs Revenue & Forecasts
5.2.1 By Application – Global IgA Nephropathy Drugs Revenue, 2018-2023
5.2.2 By Application – Global IgA Nephropathy Drugs Revenue, 2024-2029
5.2.3 By Application – Global IgA Nephropathy Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global IgA Nephropathy Drugs Market Size, 2022 & 2029
6.2 By Region – Global IgA Nephropathy Drugs Revenue & Forecasts
6.2.1 By Region – Global IgA Nephropathy Drugs Revenue, 2018-2023
6.2.2 By Region – Global IgA Nephropathy Drugs Revenue, 2024-2029
6.2.3 By Region – Global IgA Nephropathy Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America IgA Nephropathy Drugs Revenue, 2018-2029
6.3.2 US IgA Nephropathy Drugs Market Size, 2018-2029
6.3.3 Canada IgA Nephropathy Drugs Market Size, 2018-2029
6.3.4 Mexico IgA Nephropathy Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe IgA Nephropathy Drugs Revenue, 2018-2029
6.4.2 Germany IgA Nephropathy Drugs Market Size, 2018-2029
6.4.3 France IgA Nephropathy Drugs Market Size, 2018-2029
6.4.4 U.K. IgA Nephropathy Drugs Market Size, 2018-2029
6.4.5 Italy IgA Nephropathy Drugs Market Size, 2018-2029
6.4.6 Russia IgA Nephropathy Drugs Market Size, 2018-2029
6.4.7 Nordic Countries IgA Nephropathy Drugs Market Size, 2018-2029
6.4.8 Benelux IgA Nephropathy Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia IgA Nephropathy Drugs Revenue, 2018-2029
6.5.2 China IgA Nephropathy Drugs Market Size, 2018-2029
6.5.3 Japan IgA Nephropathy Drugs Market Size, 2018-2029
6.5.4 South Korea IgA Nephropathy Drugs Market Size, 2018-2029
6.5.5 Southeast Asia IgA Nephropathy Drugs Market Size, 2018-2029
6.5.6 India IgA Nephropathy Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America IgA Nephropathy Drugs Revenue, 2018-2029
6.6.2 Brazil IgA Nephropathy Drugs Market Size, 2018-2029
6.6.3 Argentina IgA Nephropathy Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa IgA Nephropathy Drugs Revenue, 2018-2029
6.7.2 Turkey IgA Nephropathy Drugs Market Size, 2018-2029
6.7.3 Israel IgA Nephropathy Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia IgA Nephropathy Drugs Market Size, 2018-2029
6.7.5 UAE IgA Nephropathy Drugs Market Size, 2018-2029
7 IgA Nephropathy Drugs Companies Profiles
7.1 Calliditas Therapeutics
7.1.1 Calliditas Therapeutics Company Summary
7.1.2 Calliditas Therapeutics Business Overview
7.1.3 Calliditas Therapeutics IgA Nephropathy Drugs Major Product Offerings
7.1.4 Calliditas Therapeutics IgA Nephropathy Drugs Revenue in Global Market (2018-2023)
7.1.5 Calliditas Therapeutics Key News & Latest Developments
7.2 Travere Therapeutics
7.2.1 Travere Therapeutics Company Summary
7.2.2 Travere Therapeutics Business Overview
7.2.3 Travere Therapeutics IgA Nephropathy Drugs Major Product Offerings
7.2.4 Travere Therapeutics IgA Nephropathy Drugs Revenue in Global Market (2018-2023)
7.2.5 Travere Therapeutics Key News & Latest Developments
7.3 Omeros Corporation
7.3.1 Omeros Corporation Company Summary
7.3.2 Omeros Corporation Business Overview
7.3.3 Omeros Corporation IgA Nephropathy Drugs Major Product Offerings
7.3.4 Omeros Corporation IgA Nephropathy Drugs Revenue in Global Market (2018-2023)
7.3.5 Omeros Corporation Key News & Latest Developments
7.4 Novartis International
7.4.1 Novartis International Company Summary
7.4.2 Novartis International Business Overview
7.4.3 Novartis International IgA Nephropathy Drugs Major Product Offerings
7.4.4 Novartis International IgA Nephropathy Drugs Revenue in Global Market (2018-2023)
7.4.5 Novartis International Key News & Latest Developments
7.5 Chinook Therapeutics
7.5.1 Chinook Therapeutics Company Summary
7.5.2 Chinook Therapeutics Business Overview
7.5.3 Chinook Therapeutics IgA Nephropathy Drugs Major Product Offerings
7.5.4 Chinook Therapeutics IgA Nephropathy Drugs Revenue in Global Market (2018-2023)
7.5.5 Chinook Therapeutics Key News & Latest Developments
7.6 Vera Therapeutics
7.6.1 Vera Therapeutics Company Summary
7.6.2 Vera Therapeutics Business Overview
7.6.3 Vera Therapeutics IgA Nephropathy Drugs Major Product Offerings
7.6.4 Vera Therapeutics IgA Nephropathy Drugs Revenue in Global Market (2018-2023)
7.6.5 Vera Therapeutics Key News & Latest Developments
7.7 Otsuka Pharmaceutical
7.7.1 Otsuka Pharmaceutical Company Summary
7.7.2 Otsuka Pharmaceutical Business Overview
7.7.3 Otsuka Pharmaceutical IgA Nephropathy Drugs Major Product Offerings
7.7.4 Otsuka Pharmaceutical IgA Nephropathy Drugs Revenue in Global Market (2018-2023)
7.7.5 Otsuka Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. IgA Nephropathy Drugs Market Opportunities & Trends in Global Market
Table 2. IgA Nephropathy Drugs Market Drivers in Global Market
Table 3. IgA Nephropathy Drugs Market Restraints in Global Market
Table 4. Key Players of IgA Nephropathy Drugs in Global Market
Table 5. Top IgA Nephropathy Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global IgA Nephropathy Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global IgA Nephropathy Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies IgA Nephropathy Drugs Product Type
Table 9. List of Global Tier 1 IgA Nephropathy Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 IgA Nephropathy Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global IgA Nephropathy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - IgA Nephropathy Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - IgA Nephropathy Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global IgA Nephropathy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - IgA Nephropathy Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - IgA Nephropathy Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global IgA Nephropathy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global IgA Nephropathy Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global IgA Nephropathy Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America IgA Nephropathy Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe IgA Nephropathy Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia IgA Nephropathy Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America IgA Nephropathy Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa IgA Nephropathy Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Calliditas Therapeutics Company Summary
Table 31. Calliditas Therapeutics IgA Nephropathy Drugs Product Offerings
Table 32. Calliditas Therapeutics IgA Nephropathy Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Calliditas Therapeutics Key News & Latest Developments
Table 34. Travere Therapeutics Company Summary
Table 35. Travere Therapeutics IgA Nephropathy Drugs Product Offerings
Table 36. Travere Therapeutics IgA Nephropathy Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Travere Therapeutics Key News & Latest Developments
Table 38. Omeros Corporation Company Summary
Table 39. Omeros Corporation IgA Nephropathy Drugs Product Offerings
Table 40. Omeros Corporation IgA Nephropathy Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Omeros Corporation Key News & Latest Developments
Table 42. Novartis International Company Summary
Table 43. Novartis International IgA Nephropathy Drugs Product Offerings
Table 44. Novartis International IgA Nephropathy Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Novartis International Key News & Latest Developments
Table 46. Chinook Therapeutics Company Summary
Table 47. Chinook Therapeutics IgA Nephropathy Drugs Product Offerings
Table 48. Chinook Therapeutics IgA Nephropathy Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Chinook Therapeutics Key News & Latest Developments
Table 50. Vera Therapeutics Company Summary
Table 51. Vera Therapeutics IgA Nephropathy Drugs Product Offerings
Table 52. Vera Therapeutics IgA Nephropathy Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Vera Therapeutics Key News & Latest Developments
Table 54. Otsuka Pharmaceutical Company Summary
Table 55. Otsuka Pharmaceutical IgA Nephropathy Drugs Product Offerings
Table 56. Otsuka Pharmaceutical IgA Nephropathy Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Otsuka Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. IgA Nephropathy Drugs Segment by Type in 2022
Figure 2. IgA Nephropathy Drugs Segment by Application in 2022
Figure 3. Global IgA Nephropathy Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global IgA Nephropathy Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global IgA Nephropathy Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by IgA Nephropathy Drugs Revenue in 2022
Figure 8. By Type - Global IgA Nephropathy Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global IgA Nephropathy Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global IgA Nephropathy Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global IgA Nephropathy Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global IgA Nephropathy Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global IgA Nephropathy Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global IgA Nephropathy Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America IgA Nephropathy Drugs Revenue Market Share, 2018-2029
Figure 16. US IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe IgA Nephropathy Drugs Revenue Market Share, 2018-2029
Figure 20. Germany IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia IgA Nephropathy Drugs Revenue Market Share, 2018-2029
Figure 28. China IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America IgA Nephropathy Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa IgA Nephropathy Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE IgA Nephropathy Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Calliditas Therapeutics IgA Nephropathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Travere Therapeutics IgA Nephropathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Omeros Corporation IgA Nephropathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Novartis International IgA Nephropathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Chinook Therapeutics IgA Nephropathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Vera Therapeutics IgA Nephropathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Otsuka Pharmaceutical IgA Nephropathy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

★調査レポート[世界のIgA腎症治療薬市場予測2023-2029：第I相、第II相、第III相] (コード：MMG23LY8799)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界のIgA腎症治療薬市場予測2023-2029：第I相、第II相、第III相]についてメールでお問い合わせ

MarketReport.jp

世界のIgA腎症治療薬市場予測2023-2029：第I相、第II相、第III相

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料 総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp